V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216658 | 20131113 | 0 | 80.3 | Palliative (P) | null | 2017-03-16 | null | 02 | N | DOXORUBICIN EMBOLISATION | 101490011 |
| 20216659 | 20131114 | 0 | 64.9 | Palliative (P) | 2019-11-16 | 2019-11-19 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101002441 |
| 20216660 | 20131115 | 0 | 83.7 | Palliative (P) | 2021-02-13 | 2021-02-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100009231 |
| 20216662 | 20131116 | 0 | 110.4 | null | 2018-03-05 | 2018-03-06 | null | 02 | null | DOXORUBICIN EMBOLISATION | 101184567 |
| 20216663 | 20131117 | 0 | null | null | 2020-02-25 | 2020-02-25 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101371209 |
| 20216665 | 20131118 | 0 | 42.3 | null | 2017-06-26 | 2017-07-25 | LENVATINIB | 02 | null | LENVATINIB | 100313118 |
| 20216667 | 20131119 | 0 | 52.4 | null | null | 2019-06-13 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100337551 |
| 20216668 | 20131120 | 0 | 75 | Palliative (P) | 2017-12-15 | 2018-01-14 | null | 02 | Y | LENVATINIB | 101365565 |
| 20216669 | 20131121 | 0 | null | Palliative (P) | 2016-12-16 | 2017-03-06 | HCX (Cape + Cisp + Tras) - Main | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101816080 |
| 20216670 | 20131122 | 0 | 76.6 | Palliative (P) | 2019-02-28 | 2019-03-21 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100021770 |
| 20216672 | 20131123 | 0 | 61.7 | null | 2016-07-29 | 2016-09-05 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101634110 |
| 20216673 | 20131124 | 0 | null | null | 2017-01-28 | 2017-02-18 | null | 02 | null | DOXORUBICIN EMBOLISATION | 101225051 |
| 20216674 | 20131125 | 0 | 73.85 | Palliative (P) | 2020-08-11 | 2020-08-11 | LENVATINIB | N | N | LENVATINIB | 101130087 |
| 20216675 | 20131126 | 0 | 55.7 | null | 2018-04-06 | 2018-04-28 | null | 99 | null | DOXORUBICIN EMBOLISATION | 101344685 |
| 20216680 | 20131129 | 1.59 | null | Curative (C) | 2013-05-27 | 2016-09-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | DOXORUBICIN EMBOLISATION | 100379447 |
| 20216681 | 20131130 | 0 | 70.6 | Palliative (P) | 2020-09-13 | 2020-09-29 | null | 02 | N | LENVATINIB | 101486881 |
| 20216682 | 20131131 | 0 | 82.8 | Palliative (P) | 2016-04-10 | 2016-09-06 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100053276 |
| 20216683 | 20131132 | 0 | 121.45 | Palliative (P) | 2020-11-20 | 2020-12-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100571906 |
| 20216685 | 20131133 | 0 | 84 | Palliative (P) | 2021-02-02 | 2021-02-20 | LANREOTIDE | 02 | N | LANREOTIDE | 101798170 |
| 20216686 | 20131134 | 0 | 65.3 | Palliative (P) | 2018-07-21 | 2018-08-06 | null | 02 | N | DOXORUBICIN EMBOLISATION | 100868981 |
| 20216688 | 20131136 | 0 | null | Palliative (P) | 2019-03-04 | 2019-03-14 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100603807 |
| 20216689 | 20131137 | 0 | 80 | null | 2019-12-24 | 2019-12-24 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100016514 |
| 20216690 | 20131138 | 0 | null | Palliative (P) | 2016-09-23 | 2017-07-11 | null | 02 | N | CAPECITABINE + MITOMYCIN | 101094116 |
| 20216691 | 20131139 | 0 | 63.55 | Curative (C) | 2020-01-02 | 2020-01-02 | null | 99 | N | DOXORUBICIN EMBOLISATION | 101511250 |
| 20216695 | 20131140 | 1.62 | null | Palliative (P) | 2016-12-19 | 2018-09-20 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101787616 |
| 20216697 | 20131141 | 0 | null | null | 2018-03-22 | 2018-04-28 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100037770 |
| 20216700 | 20131143 | null | null | Curative (C) | null | 2018-07-02 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101779223 |
| 20216701 | 20131144 | 0 | 57 | null | null | 2018-12-07 | LENVATINIB | 02 | null | LENVATINIB | 100720289 |
| 20216702 | 20131145 | 0 | null | null | null | 2018-06-04 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100102701 |
| 20216703 | 20131146 | 0 | 72.6 | Palliative (P) | 2020-01-03 | 2020-09-21 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100399522 |
| 20216704 | 20131147 | 0 | 85.5 | null | 2019-09-10 | 2019-11-05 | HCX | 99 | null | DOXORUBICIN EMBOLISATION | 100428088 |
| 20216705 | 20131148 | 0 | 89.2 | null | null | 2018-01-12 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100139758 |
| 20216706 | 20131149 | 1.89 | 93 | null | 2018-04-03 | 2018-04-17 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100410699 |
| 20216707 | 20131150 | 0 | null | Curative (C) | 2018-05-26 | 2018-07-19 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN | 101652648 |
| 20216708 | 20131151 | 0 | 51 | Curative (C) | 2017-05-06 | 2017-05-06 | null | 02 | N | DOXORUBICIN EMBOLISATION | 100234882 |
| 20216710 | 20131152 | 0 | 71.9 | Palliative (P) | null | 2019-09-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100887957 |
| 20216711 | 20131153 | 0 | 71.8 | null | 2016-06-21 | 2017-06-23 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101139585 |
| 20216712 | 20131154 | 0 | null | Curative (C) | 2017-11-18 | 2017-12-09 | null | 02 | Y | DOXORUBICIN EMBOLISATION | 100852321 |
| 20216714 | 20131155 | 0 | 126 | null | 2018-02-13 | 2018-06-24 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101092613 |
| 20216716 | 20131156 | 0 | 102.3 | null | 2020-05-21 | 2020-06-11 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101153928 |
| 20216719 | 20131157 | 0 | 92.4 | null | 2016-08-20 | 2018-07-14 | Doxorubicin chemoembolisation | 2 | null | DOXORUBICIN EMBOLISATION | 100244353 |
| 20216720 | 20131158 | 0 | 58.6 | 03 | 2021-05-17 | 2021-06-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100743400 |
| 20216722 | 20131159 | 0 | 60 | null | 2017-02-08 | 2017-03-01 | null | 99 | null | DOXORUBICIN EMBOLISATION | 100987004 |
| 20216723 | 20131160 | 0 | 80 | null | 2016-03-10 | 2016-04-08 | LENVATINIB | 02 | null | LENVATINIB | 100300263 |
| 20216724 | 20131161 | 0 | 0 | null | 2017-01-23 | 2017-02-02 | null | 99 | null | DOXORUBICIN EMBOLISATION | 100546967 |
| 20216725 | 20131162 | 0 | 83.5 | Neo-adjuvant (N) | 2017-06-06 | 2017-11-09 | null | 02 | null | LENVATINIB | 100872703 |
| 20216726 | 20131163 | 0 | 114 | Adjuvant (A) | 2021-06-29 | 2021-07-11 | Cape+Cisplatin+Trastuzumab Main | 02 | N | DOXORUBICIN EMBOLISATION | 101614751 |
| 20216727 | 20131164 | 0 | null | Curative (C) | 2018-09-26 | 2018-09-29 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100346595 |
| 20216730 | 20131165 | 0 | null | Curative (C) | 2020-01-25 | 2020-02-10 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100549028 |
| 20216731 | 20131166 | 0 | null | null | 2020-04-29 | 2020-05-13 | null | 02 | null | DOXORUBICIN EMBOLISATION | 100670296 |